Clinical Trial Update: Degarelix Before Radical Prostatectomy [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial update evaluating degarelix before radical prostatectomy for prostate cancer. The trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Firmagon (degarelix) (degarelix)

Snippet

Sponsor: University of Cambridge | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: UNKNOWN